Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Emerging immunotherapies for glioblastoma
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
Oncolytic virotherapy for urological cancers
In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy
Dendritic cell-based cancer immunotherapy for colorectal cancer
Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy
Cancer Vaccines in Ovarian Cancer: How Can We Improve?
Veröffentlichung von Stefaan Van Gool MD. PhD.: Electroporation of Dendritic Cells with WT1, Survivin, and TriMix
Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro
T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines
Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer